Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Pancreatic Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01534637
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerNauseaVomiting+3 more
Wake Forest University Health Sciences 22
Not applicableEnded earlyNCT00003851
What this trial is testing

Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer

Who this might be right for
MalnutritionPancreatic Cancer
Columbia University 90
Testing effectiveness (Phase 2)Study completedNCT00114179
What this trial is testing

Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
National Cancer Institute (NCI) 82
Testing effectiveness (Phase 2)Study completedNCT00383760
What this trial is testing

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerRecurrent Pancreatic Cancer+3 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT02394535
What this trial is testing

Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+4 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04539808
What this trial is testing

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage 0 Pancreatic Cancer American Joint Committee on Cancer v8Stage I Pancreatic Cancer American Joint Committee on Cancer v8+2 more
OHSU Knight Cancer Institute
Not applicableLooking for participantsNCT07124611
What this trial is testing

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Localized Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8Stage I Pancreatic Cancer AJCC v8+1 more
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Temporarily pausedNCT04111172
What this trial is testing

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more
Thomas Jefferson University 48
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Ended earlyNCT03825289
What this trial is testing

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CarcinomaStage II Pancreatic CancerStage IIA Pancreatic Cancer+4 more
University of Utah 25
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT00960284
What this trial is testing

Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 102
Not applicableStudy completedNCT00369109
What this trial is testing

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer
Barbara Ann Karmanos Cancer Institute 60
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Very early researchStudy completedNCT01821612
What this trial is testing

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Alliance for Clinical Trials in Oncology 23
Early research (Phase 1)Ended earlyNCT00310050
What this trial is testing

Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wake Forest University Health Sciences 4
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00003426
What this trial is testing

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Next Page
42